valoctocogene roxaparvovec Infusion bulk supplier for pharma manufacturers

Valoctocogene Roxaparvovec Infusion Suppliers & Bulk Manufacturers

Available Forms: Intravenous infusion

Available Strengths: A single-dose gene therapy designed to increase factor VIII production in hemophilia A patients

Reference Brands: Roctavian(US & EU)

Category: Cell & Gene Therapies

Valoctocogene roxaparvovec (Roctavian) is a gene therapy that delivers a functional factor VIII gene via viral vectors, enabling the body to produce sustained, high levels of the clotting factor. It reduces bleeding episodes, decreases treatment burden, and improves quality of life in patients with severe hemophilia A.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Valoctocogene roxaparvovec (Roctavian) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involved extensive clinical trials and safety assessments, while in the EU, regulatory review is ongoing, with CE marking anticipated. These gene therapies undergo validation, stability testing, and audits, supported by detailed documentation, including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to innovative, long-lasting gene therapy treatments for hemophilia A worldwide, supporting improved patient outcomes and advanced healthcare.

Valoctocogene Roxaparvovec Infusion — third party manufacturing & bulk supply

Valoctocogene Roxaparvovec Infusion is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Valoctocogene Roxaparvovec Infusion is supplied as Intravenous infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Valoctocogene Roxaparvovec Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Valoctocogene Roxaparvovec Infusion →

Back to Listing

Frequently Asked Questions

valoctocogene roxaparvovec Infusion is listed as Intravenous infusion in A single-dose gene therapy designed to increase factor VIII production in hemophilia A patients. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

valoctocogene roxaparvovec Infusion is referenced against Roctavian(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.